Clinical Trial Update: Melatonin and Perinatal Outcomes in MVM-Related Fetal Growth Restriction (MIMVMFGR) [Phase 1]

View source ↗

Summary

This clinical trial update indicates a Phase 1 study evaluating melatonin for perinatal outcomes in pregnancies affected by MVM-related fetal growth restriction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fetal Growth Restriction

Drugs mentioned

• Melatonin (melatonin)

Snippet

Sponsor: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Fetal Growth Restriction (FGR) | Phase 1 | Status: ENROLLING_BY_INVITATION